» Articles » PMID: 17916549

Ultrasound-based Transient Elastography for the Detection of Hepatic Fibrosis: Systematic Review and Meta-analysis

Overview
Specialty Gastroenterology
Date 2007 Oct 6
PMID 17916549
Citations 165
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Ultrasound-based transient elastography is a promising noninvasive alternative to liver biopsy for detecting hepatic fibrosis. However, its overall test performance in various settings remains unknown. The aims of this study were to perform a systematic review and meta-analysis of diagnostic accuracy studies comparing ultrasound-based transient elastography with liver biopsy for hepatic fibrosis.

Methods: Electronic and manual bibliographic searches to identify potential studies were performed. Selection of studies was based on reported accuracy of ultrasound-based transient elastography compared with liver biopsy. Data extraction was performed independently by 2 reviewers. Meta-analysis combined the sensitivities, specificities, and likelihood ratios of individual studies. Extent and reasons for heterogeneity were assessed.

Results: Nine studies in full publication were identified. For patients with stage IV fibrosis (cirrhosis), the pooled estimates for sensitivity were 87% (95% confidence interval [CI], 84%-90%), specificity 91% (95% CI, 89%-92%), positive likelihood ratio 11.7 (95% CI, 7.9-17.1), and negative likelihood ratio 0.14 (95% CI, 0.10-0.20). Among 7 investigations reporting patients with stages II-IV fibrosis, the pooled estimates for sensitivity were 70% (95% CI, 67%-73%), specificity 84% (95% CI, 80%-88%), positive likelihood ratio 4.2 (95% CI, 2.4-7.2), and negative likelihood ratio 0.31 (95% CI, 0.23-0.43). Diagnostic threshold (or cut-off value) bias was identified as an important cause of heterogeneity for pooled results in both patient groups.

Conclusions: Ultrasound-based transient elastography appears to be a clinically useful test for detecting cirrhosis.

Citing Articles

Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison.

Pozowski P, Bilski M, Bedrylo M, Sitny P, Zaleska-Dorobisz U World J Hepatol. 2025; 17(2):100033.

PMID: 40027573 PMC: 11866135. DOI: 10.4254/wjh.v17.i2.100033.


Prevalence of Clinically Significant Liver Fibrosis as Measured by Transient Elastography due to Non-alcoholic Fatty Liver Disease in Indian Individuals with Type 2 Diabetes Mellitus.

Deb R, Goswami S, Sengupta N, Baidya A, Khare V, Datta J Indian J Endocrinol Metab. 2024; 28(4):385-390.

PMID: 39371654 PMC: 11451953. DOI: 10.4103/ijem.ijem_203_23.


Liver Fibrosis and Cirrhosis in Patients with Non-alcoholic Fatty Liver with and without History of Cholecystectomy: A Pilot Study.

Parsi A, Hajiani E, Sadani S, Hashemi S, Seyedian S, Alimadadi M Middle East J Dig Dis. 2024; 16(1):34-38.

PMID: 39050095 PMC: 11264833. DOI: 10.34172/mejdd.2024.366.


Multiparametric ultrasound as a new concept of assessment of liver tissue damage.

Peltec A, Sporea I World J Gastroenterol. 2024; 30(12):1663-1669.

PMID: 38617743 PMC: 11008374. DOI: 10.3748/wjg.v30.i12.1663.


Noninvasive Methods for Assessing Liver Fibrosis and Steatosis.

Kazi I, Kuo L, Tsai E Gastroenterol Hepatol (N Y). 2024; 20(1):21-29.

PMID: 38405045 PMC: 10885415.